Clinical Trial Update: A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for laquinimod in active lupus arthritis (systemic lupus erythematosus).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Laquinimod (laquinimod)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Lupus Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2022-07-07